CSL Behring today announced that Kcentra ® (Prothrombin Complex Concentrate [Human]) has received U.S. Food and Drug Administration (FDA) approval for an expanded indication -- urgent reversal of ...
KING OF PRUSSIA, Pa., March 17, 2015 /PRNewswire/ -- CSL Behring today announced that The Lancet has published results from a Phase III clinical study showing Kcentra (Prothrombin Complex Concentrate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results